NIDA Director Nora Volkow announced release of ARRA funds in September to develop the first phase III trial of a smoking cessation vaccine, NicVAX, designed to help people quit and remain abstinent.  Read more...

Cocaine vaccine clinical trial is the first successful, placebo-controlled demonstration of a vaccine against an illicit drug of abuse.  Baylor Medications Development Center (MDC) led the research teams in Texas and Connecticut.  Read more...

Multisite Prevention Trial (MPT) scientists found that involved-supportive parenting could moderate the association between a genetic vulnerability factor and longitudinal increases in substance use.

In the CJ-DATS network, scientists examined the relationship between substance use, mental health problems and violence among offenders released from prison and referred to treatment programs.

November 2, 2009
The National Drug Abuse Treatment Clinical Trials Network (U10) (RFA-DA-10-009), FAQs

November 18, 2009
International Research Collaborations on HIV/AIDS and Drug Use (R01) (RFA-DA-10-008)

December 11, 2009
Recovery Act Limited Competition: Building Sustainable Community-Linked Infrastructure to Enable Health Science Research (RC4) RFA-OD-09-010

December 22, 2009
Substance Use and Abuse among U.S. Military Personnel, Veterans and their Families,(R01) RFA-DA-10-001,(R21) RFA-DA-10-002

November 2, 2009
Training (T32) Director’s Meeting, Bethesda Marriott, Bethesda, MD

December 15-16, 2009
Clinically Meaningful Substance Abuse Treatment Outcome Measure(s) for Clinical Research - Marriott Bethesda North, Bethesda, MD